Nanalysis Scientific Corp. (V:NSCI)

Business Focus: Advanced Medical Equipment & Technology (NEC)

Get the company report for the most recent outlook updated daily

Apr 11, 2024 08:30 am ET

Nanalysis Announces Full Year 2023 Conference Call

Hosting Call at 5:00 pm ET on Thursday, April 25th

Apr 11, 2024 08:30 am ET

Nanalysis Announces Full Year 2023 Conference Call

Hosting Call at 5:00 pm ET on Thursday, April 25th

Apr 10, 2024 09:55 am ET

Nanalysis Scientific Corp. Announces Director Resignation

CALGARY, AB, April 10, 2024 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) announces that Kham Lin has resigned as a director of the Company effective April 9, 2024, and the Board of Directors has accepted his resignation. The Company would like to thank Mr. Lin for his contributions throughout his tenure as director of the Company.

Apr 10, 2024 09:55 am ET

Nanalysis Scientific Corp. Announces Director Resignation

CALGARY, AB, April 10, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) announces that Kham Lin has resigned as a director of the Company effective April 9, 2024, and the Board of Directors has accepted his resignation. The Company would like to thank Mr. Lin for his contributions throughout his tenure as director of the Company.

Apr 04, 2024 08:30 am ET

Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances

CALGARY, AB, April 4, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that its subsidiary Nanalysis Corp. is receiving advisory services and up to $1.45 million in non-repayable, non-dilutive funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), to develop Artificial Intelligence based software tools to detect illicit substances on top of the Company

Apr 04, 2024 08:30 am ET

Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances

CALGARY, AB, April 4, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that its subsidiary Nanalysis Corp. is receiving advisory services and up to $1.45 million in non-repayable, non-dilutive funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), to develop Artificial Intelligence based software tools to detect illicit substances on top of the

Mar 20, 2024 09:32 am ET

NANALYSIS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND CONCURRENT PRIVATE PLACEMENT

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

Mar 06, 2024 03:15 pm ET

Canadian Investment Regulatory Organization Trade Resumption - NSCI

VANCOUVER, BC, March 6, 2024 /CNW/ - Trading resumes in:

Mar 06, 2024 03:07 pm ET

Canadian Investment Regulatory Organization Trading Halt - NSCI

VANCOUVER, BC, March 6, 2024 /CNW/ - The following issues have been halted by CIRO

Mar 06, 2024 03:00 pm ET

NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MILLION CONCURRENT PRIVATE PLACEMENT

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Feb 07, 2024 07:30 am ET

Nanalysis Announces Upcoming Webinar and Conference Participation

CALGARY, AB, Feb. 7, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that Founder and CEO Sane Krakiwsky will be participating in an upcoming webinar and conference.

Feb 07, 2024 07:30 am ET

Nanalysis Announces Upcoming Webinar and Conference Participation

CALGARY, AB, Feb. 7, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, announces that Founder and CEO Sane Krakiwsky will be participating in an upcoming webinar and conference.

Feb 06, 2024 07:30 am ET

Nanalysis Achieves Record Revenue in Q4

CALGARY, AB, Feb. 6, 2024 /CNW/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, provides an estimate of Q4 2023 unaudited revenue and highlights some other recent business accomplishments.

Feb 06, 2024 07:30 am ET

Nanalysis Achieves Record Revenue in Q4

CALGARY, AB, Feb. 6, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines, MRI technology for industrial and research applications, and detection equipment services, provides an estimate of Q4 2023 unaudited revenue and highlights some other recent business accomplishments.

Jan 30, 2024 07:30 am ET

Nanalysis Scientific Corp. Provides Update on Security Services Business

Phase-In of Canada-Wide Coverage at All 89 Designated Airports Completed on January 11, 2024

Jan 30, 2024 07:30 am ET

Nanalysis Scientific Corp. Provides Update on Security Services Business

Phase-In of Canada-Wide Coverage at All 89 Designated Airports Completed on January 11, 2024

Jan 03, 2024 06:11 pm ET

Nanalysis Scientific Corp. Announces Grant of Restricted Share Units

CALGARY, AB, Jan. 3, 2024 /CNW/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted 475,000 Restricted Share Units ("RSU"s) to its independent Directors, pursuant to the Company's RSU plan. Each RSU is exercisable for one common share in the capital of the Company for a period ending at the end of the calendar year, three years after the date of grant. 100,000 of the RSUs vest immediately, and the remaining RSUs vest as to one-third on each of the 12-month, 24-month, and 36-month anniversar

Jan 03, 2024 06:11 pm ET

Nanalysis Scientific Corp. Announces Grant of Restricted Share Units

CALGARY, AB, Jan. 3, 2024 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted 475,000 Restricted Share Units ("RSU"s) to its independent Directors, pursuant to the Company's RSU plan. Each RSU is exercisable for one common share in the capital of the Company for a period ending at the end of the calendar year, three years after the date of grant. 100,000 of the RSUs vest immediately, and the remaining RSUs vest as to one-third on each of the 12-month, 24-month, and 36-month ann

Nov 29, 2023 04:19 pm ET

Nanalysis Reports Third Quarter 2023 Results

CALGARY, AB, Nov. 29, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its third quarter results ending September 30, 2023. Chief Executive Officer, Sean Krakiwsky, and Chief Financial Officer, Randall McRae, will host a conference call at 5 P.M. Eastern Time today to discuss the results.

Nov 29, 2023 04:19 pm ET

Nanalysis Reports Third Quarter 2023 Results

CALGARY, AB, Nov. 29, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its third quarter results ending September 30, 2023. Chief Executive Officer, Sean Krakiwsky, and Chief Financial Officer, Randall McRae, will host a conference call at 5 P.M. Eastern Time today to discuss the results.

Nov 15, 2023 07:30 am ET

Nanalysis Announces Third Quarter 2023 Conference Call

Hosting Call at 5:00 pm ET on Wednesday, November 29th

Nov 15, 2023 07:30 am ET

Nanalysis Announces Third Quarter 2023 Conference Call

Hosting Call at 5:00 pm ET on Wednesday, November 29th

Sep 05, 2023 09:00 am ET

Keynote Speakers and 34 Companies to Present at the Planet MicroCap Showcase: VANCOUVER on September 6-7, 2023 at the Fairmont Waterfront Vancouver

VANCOUVER, BC / ACCESSWIRE / September 5, 2023 / Planet MicroCap presents the Planet MicroCap Showcase: VANCOUVER taking place on September 6-7, 2023, where 29 MicroCap public companies will be presenting at the Fairmont Waterfront Vancouver, and 5 MicroCap public companies will be presenting virtually.

Aug 30, 2023 08:30 am ET

Nanalysis to Present at the Planet MicroCap Showcase: VANCOUVER 2023 on Wednesday, September 6, 2023 & 1x1 Meetings on Thursday, September 7, 2023

CALGARY, AB, Aug. 30, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that it will be presenting at the Planet MicroCap Showcase: VANCOUVER 2023 on Wednesday, September 6, 2023 at 9:30 AM PST. CEO and Founder Sean Krakiwsky will be hosting the presentation and answering questions at the conclusion.

Aug 24, 2023 04:05 pm ET

Nanalysis Reports Second Quarter 2023 Results

CALGARY, AB, Aug. 24, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its second quarter results ending June 30, 2023. Chief Executive Officer, Sean Krakiwsky, and Chief Financial Officer, Randall McRae, will host a conference call at 5 P.M. Eastern Time today to discuss the results.

Aug 15, 2023 08:30 am ET

Nanalysis Announces Second Quarter 2023 Conference Call

Hosting Call at 5:00 pm ET on Thursday, August 24th

Jun 30, 2023 06:23 pm ET

TSX Venture Exchange Stock Maintenance Bulletins

VANCOUVER, BC, June 30, 2023 /CNW/ -

Jun 29, 2023 07:40 pm ET

Nanalysis Enters into New Credit Facility with ATB Financial

CALGARY, AB, June 29, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), , a leader in portable NMR machines and MRI technology for industrial and research applications, is pleased to announce that it has entered into a commitment letter with ATB Financial (the "Credit Agreement"). Under the Credit Agreement, ATB Financial has made available to the Company a senior secured term loan in the principal amount of up to $10 million and a senior secured revolving operating line in the principal amount of up to $5 million (the "Credit Facili

Jun 29, 2023 07:40 pm ET

Nanalysis Enters into New Credit Facility with ATB Financial

CALGARY, AB, June 29, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company" or "Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), , a leader in portable NMR machines and MRI technology for industrial and research applications, is pleased to announce that it has entered into a commitment letter with ATB Financial (the "Credit Agreement"). Under the Credit Agreement, ATB Financial has made available to the Company a senior secured term loan in the principal amount of up to $10 million and a senior secured revolving operating line in the principal amount of up to $5 million (the "Credit

Jun 20, 2023 04:05 pm ET

Nanalysis To Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar

Webinar tomorrow Weds, June 21st at 2:00pm ET/11AM MDT

Jun 20, 2023 04:05 pm ET

Nanalysis To Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar

Webinar tomorrow Weds, June 21st at 2:00pm ET/11AM MDT

Jun 15, 2023 09:07 am ET

Nanalysis Announces Annual General Meeting

Meeting to Be Held on Wednesday, June 28th at 9:00 AM MDT

Jun 15, 2023 09:07 am ET

Nanalysis Announces Annual General Meeting

Meeting to Be Held on Wednesday, June 28th at 9:00 AM MDT

May 31, 2023 08:45 am ET

Nanalysis to Present at LD Micro Invitational XIII

Presentation on Tuesday, June 6th at 1:30 PM PT

May 31, 2023 08:45 am ET

Nanalysis to Present at LD Micro Invitational XIII

Presentation on Tuesday, June 6th at 1:30 PM PT

May 25, 2023 04:05 pm ET

Nanalysis Reports First Quarter 2023 Results

CALGARY, AB, May 25, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its first quarter results ending March 31, 2023. Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. The second call for European investors at 8:30am ET, tomorrow, Friday, May 26 has been cancelled since Mr. Krakiwsky will be conducting meetings in person.

May 25, 2023 04:05 pm ET

Nanalysis Reports First Quarter 2023 Results

CALGARY, AB, May 25, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its first quarter results ending March 31, 2023. Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. The second call for European investors at 8:30am ET, tomorrow, Friday, May 26 has been cancelled since Mr. Krakiwsky will be conducting meetings in person.

May 18, 2023 08:30 am ET

Nanalysis Announces First Quarter 2023 Conference Call

Hosting Call at 5:00 pm ET on Thursday, May 25th

May 18, 2023 08:30 am ET

Nanalysis Announces First Quarter 2023 Conference Call

Hosting Call at 5:00 pm ET on Thursday, May 25th

May 11, 2023 12:07 am ET

TSX Venture Exchange Stock Maintenance Bulletins

VANCOUVER, BC, May 10, 2023 /CNW/ -

May 03, 2023 04:05 pm ET

Nanalysis Scientific Corp. Announces Closing of Second Tranche to Fully Complete its $4,128,700 Offering

CALGARY, AB, May 3, 2023 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce, further to its news releases dated April 21, 2023, April 26, 2023 and May 1, 2023, it has successfully closed the second and final tranche (the "Second Tranche") of its $4,128,700 non-brokered private placement (the "Offering").

May 03, 2023 04:05 pm ET

Nanalysis Scientific Corp. Announces Closing of Second Tranche to Fully Complete its $4,128,700 Offering

CALGARY, AB, May 3, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce, further to its news releases dated April 21, 2023, April 26, 2023 and May 1, 2023, it has successfully closed the second and final tranche (the "Second Tranche") of its $4,128,700 non-brokered private placement (the "Offering").

May 01, 2023 08:30 am ET

Nanalysis Scientific Corp. Announces Upsize to Private Placement of Units

CALGARY, AB, May 1, 2023 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that due to strong investor demand, the Company has increased the size of its previously announced non-brokered private placement of units of the Company (the "Units"). The Company will now issue up to 6,881,167 Units at a price of $0.60 per Unit for aggregate gross ‎proceeds of up to $4,128,700 (the "Offering").

May 01, 2023 08:30 am ET

Nanalysis Scientific Corp. Announces Upsize to Private Placement of Units

CALGARY, AB, May 1, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that due to strong investor demand, the Company has increased the size of its previously announced non-brokered private placement of units of the Company (the "Units"). The Company will now issue up to 6,881,167 Units at a price of $0.60 per Unit for aggregate gross ‎proceeds of up to $4,128,700 (the "Offering").

Apr 27, 2023 04:33 pm ET

Nanalysis Reports Fourth Quarter and Full Year 2022 Results

CALGARY, AB, April 27, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its fourth quarter and full year results ending December 31, 2022. Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am ET on Friday, April 28th. All interested parties are invited to join these calls.

Apr 27, 2023 04:33 pm ET

Nanalysis Reports Fourth Quarter and Full Year 2022 Results

CALGARY, AB, April 27, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its fourth quarter and full year results ending December 31, 2022. Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am ET on Friday, April 28th. All interested parties are invited to join these calls

Apr 26, 2023 04:05 pm ET

Nanalysis Scientific Corp. Announces Closing of First Tranche of Private Placement

CALGARY, AB, April 26, 2023 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce it has closed the first tranche of its previously announced non-brokered private placement on April 21, 2023 (the "Offering").The Company has issued a total of 3,738,667 units ("Units") ‎at a price of $0.60 per Unit for gross proceeds of $2,243,200. Each Unit consisted of one common share in the capital of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"). Each Warrant entitles the holder thereof to purchase

Apr 26, 2023 04:05 pm ET

Nanalysis Scientific Corp. Announces Closing of First Tranche of Private Placement

CALGARY, AB, April 26, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce it has closed the first tranche of its previously announced non-brokered private placement on April 21, 2023 (the "Offering").The Company has issued a total of 3,738,667 units ("Units") ‎at a price of $0.60 per Unit for gross proceeds of $2,243,200. Each Unit consisted of one common share in the capital of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"). Each Warrant entitles the holder thereof to pu

Apr 21, 2023 04:05 pm ET

Nanalysis Scientific Corp. Announces $3.5 Million Private Placement

CALGARY, AB, April 21, 2023 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that it intends to complete a non-brokered private placement (the "Offering") ‎of up to 5,833,333 units of the Company (the "Units") at a price of $0.60 per Unit for aggregate gross proceeds of up to $3,500,000. ‎

Apr 21, 2023 04:05 pm ET

Nanalysis Scientific Corp. Announces $3.5 Million Private Placement

CALGARY, AB, April 21, 2023 /PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that it intends to complete a non-brokered private placement (the "Offering") ‎of up to 5,833,333 units of the Company (the "Units") at a price of $0.60 per Unit for aggregate gross proceeds of up to $3,500,000. ‎

Apr 18, 2023 08:30 am ET

Nanalysis and QUAD Systems Launch Full 400MHz High Field System

Nanalysis Collaborated on and Supplies Key Components of the System

Apr 18, 2023 08:30 am ET

Nanalysis and QUAD Systems Launch Full 400MHz High Field System

Nanalysis Collaborated on and Supplies Key Components of the System

Apr 12, 2023 08:30 am ET

Nanalysis Announces Fourth Quarter and Full Year 2022 Conference Call

Hosting Call at 5:00 pm ET on Thursday, April 27th

Apr 12, 2023 08:30 am ET

Nanalysis Announces Fourth Quarter and Full Year 2022 Conference Call

Hosting Call at 5:00 pm ET on Thursday, April 27th

Mar 16, 2023 04:05 pm ET

Nanalysis Scientific Corp. to Participate in the Industrial Tech Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

On Growing Opportunities in Medical & Industrial Tech Markets Panel at 1 pm ET on March 21st

Mar 16, 2023 04:05 pm ET

Nanalysis Scientific Corp. to Participate in the Industrial Tech Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

On Growing Opportunities in Medical & Industrial Tech Markets Panel at 1 pm ET on March 21st

Mar 14, 2023 08:30 am ET

Nanalysis Scientific Corp. Announces Grant of Stock Options

CALGARY, AB, March 14, 2023 /CNW/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted 335,000 stock options to Directors and Officers of the Company, pursuant to the Company's stock option plan. Each option is exercisable to purchase one common share in the capital of the Company at $1.10 per share for a period of five years from the date of issuance. The options vest as to one-third on each of the 12 month, 24 month, and 36 month anniversary date of grant. In addition, the Company granted

Mar 14, 2023 08:30 am ET

Nanalysis Scientific Corp. Announces Grant of Stock Options

CALGARY, AB, March 14, 2023 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted 335,000 stock options to Directors and Officers of the Company, pursuant to the Company's stock option plan. Each option is exercisable to purchase one common share in the capital of the Company at $1.10 per share for a period of five years from the date of issuance. The options vest as to one-third on each of the 12 month, 24 month, and 36 month anniversary date of grant. In addition, the Company g

Feb 28, 2023 07:30 am ET

Nanalysis Announces Appointment of Randall McRae as CFO

CALGARY, AB, Feb. 28, 2023 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, announces the appointment of Randall McRae to Chief Financial Officer.

Nov 29, 2022 03:05 pm ET

Nanalysis Reports Third Quarter 2022 Results

CALGARY, AB, Nov. 29, 2022 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, releases its second quarter results ending September 30, 2022. Chief Executive Officer, Sean Krakiwsky and Interim Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am ET on Wednesday, November 30th. All interested parties are invited to join these calls.

Nov 29, 2022 03:05 pm ET

Nanalysis Reports Third Quarter 2022 Results

CALGARY, AB, Nov. 29, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, releases its second quarter results ending September 30, 2022. Chief Executive Officer, Sean Krakiwsky and Interim Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am ET on Wednesday, November 30th. All interested parties are invited to join these

Nov 15, 2022 07:30 am ET

Nanalysis Announces Third Quarter 2022 Conference Call

Hosting Call at 5:00 pm ET on Tuesday, November 29thEuropean Q&A Session on November 30th at 8:30am ET

Nov 15, 2022 07:30 am ET

Nanalysis Announces Third Quarter 2022 Conference Call

Hosting Call at 5:00 pm ET on Tuesday, November 29thEuropean Q&A Session on November 30th at 8:30am ET

Oct 20, 2022 08:30 am ET

Nanalysis Provides Corporate Update

Preliminary Q3 Revenue Expected to be at least $6.8 million

Oct 20, 2022 08:30 am ET

Nanalysis Provides Corporate Update

Preliminary Q3 Revenue Expected to be at least $6.8 million

Oct 18, 2022 08:30 am ET

Nanalysis to Present at LD Micro Main Event XV Investor Conference Presentation is Tuesday, Oct. 25th at 2:00pm PT

Calgary, Alberta--(Newsfile Corp. - October 18, 2022) - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FSE: 1N1) ("the Company"), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, announces that Sean Krakiwsky, Founder and CEO of Nanalysis will present at LD Micro's Main Event XV.

Aug 30, 2022 05:09 pm ET

Nanalysis Scientific Corp. Announces Grant of Stock Options

CALGARY, AB, Aug. 30, 2022 /CNW/ - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted a total of 377,500 stock options to its employees, including 175,000 to an officer, pursuant to the Company's stock option plan. Each option is exercisable to purchase one common share in the capital of the Company at $1.10 per share for a period of five years from the date of issuance. The options vest as to one-third on each of the 12 month, 24 month and 36 month anniversary date of grant.

Aug 30, 2022 05:09 pm ET

Nanalysis Scientific Corp. Announces Grant of Stock Options

CALGARY, AB, Aug. 30, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted a total of 377,500 stock options to its employees, including 175,000 to an officer, pursuant to the Company's stock option plan. Each option is exercisable to purchase one common share in the capital of the Company at $1.10 per share for a period of five years from the date of issuance. The options vest as to one-third on each of the 12 month, 24 month and 36 month anniversary date of grant.

Aug 25, 2022 04:05 pm ET

Nanalysis Reports Second Quarter 2022 Results

CALGARY, AB, Aug. 25, 2022 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, releases its second quarter results ending June 30, 2022. Chief Executive Officer, Sean Krakiwsky and Interim Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am ET on Friday, August 26th. All interested parties are invited to join these calls.

Aug 25, 2022 04:05 pm ET

Nanalysis Reports Second Quarter 2022 Results

CALGARY, AB, Aug. 25, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, releases its second quarter results ending June 30, 2022. Chief Executive Officer, Sean Krakiwsky and Interim Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am ET on Friday, August 26th. All interested parties are invited to join these calls.

Aug 10, 2022 08:30 am ET

Nanalysis Announces Second Quarter 2022 Conference Call

Hosting Call at 5:00 pm ET on Thursday, August 25th

Aug 10, 2022 08:30 am ET

Nanalysis Announces Second Quarter 2022 Conference Call

Hosting Call at 5:00 pm ET on Thursday, August 25th

Jul 21, 2022 04:05 pm ET

Nanalysis Scientific Corp. Announces Management Transitions

CALGARY, AB, July 21, 2022 /CNW/ - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the current CFO, Luke Caplette, is stepping down as CFO, but will remain with the Company as a part-time consultant to assist the transition to a new CFO. The Company is pleased that its Corporate Controller, Randall McRae, has been appointed interim-CFO.

Jul 21, 2022 04:05 pm ET

Nanalysis Scientific Corp. Announces Management Transitions

CALGARY, AB, July 21, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the current CFO, Luke Caplette, is stepping down as CFO, but will remain with the Company as a part-time consultant to assist the transition to a new CFO. The Company is pleased that its Corporate Controller, Randall McRae, has been appointed interim-CFO.

Jun 23, 2022 08:30 am ET

Nanalysis Announces Results of AGM and Appointment of New Director

CALGARY, AB, June 23, 2022 /CNW/ - Nanalysis Scientific Corp. ("the Company", ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, is pleased to report that all proposed resolutions were approved at the Company's Annual General and Special Meeting of shareholders held on June 22, 2022 (the "Meeting"). The number of directors was set at 7 and all director nominees, as listed in the Management Information Circular dated May 20, 2022 (the "Information Circular"), were elected as directors of the Com

Jun 23, 2022 08:30 am ET

Nanalysis Announces Results of AGM and Appointment of New Director

CALGARY, AB, June 23, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, is pleased to report that all proposed resolutions were approved at the Company's Annual General and Special Meeting of shareholders held on June 22, 2022 (the "Meeting"). The number of directors was set at 7 and all director nominees, as listed in the Management Information Circular dated May 20, 2022 (the "Information Circular"), were elected as directors of

Jun 17, 2022 08:35 am ET

OTCQX Best 50 Virtual Investor Conference: Now Available for On-Demand Viewing

Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the June 16th OTCQX Best 50 Virtual Investor Conference are now available for on-demand viewing. REGISTER NOW OR LOGIN...

Jun 10, 2022 08:35 am ET

OTCQX Best 50 Virtual Investor Conference: Company Executives Present June 16th

Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming OTCQX Best 50 Companies Virtual Investor Conference to be held on June 16th. Individual investors, institutional...

Jun 06, 2022 08:30 am ET

Nanalysis Presenting at Upcoming Conferences

LD Micro on June 7-8th

Jun 06, 2022 08:30 am ET

Nanalysis Presenting at Upcoming Conferences

LD Micro on June 7-8th

May 31, 2022 08:40 am ET

Nanalysis Reports First Quarter 2022 Results

Hosting Call Today at 5pm ET

May 31, 2022 08:40 am ET

Nanalysis Reports First Quarter 2022 Results

Hosting Call Today at 5pm ET

May 26, 2022 08:30 am ET

Nanalysis Scientific Corp. Announces $160 Million Multi Year Contract Win

CALGARY, AB, May 26, 2022 /CNW/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's wholly-owned subsidiary K'(Prime) Technologies (KPrime) has won a six year $160 million service and maintenance contract with Canadian Air Transportation Security Authority ("CATSA"), which includes a gradual phase in period of approximately one year. Furthermore, it is common for these types of contracts to be renewed for an additional five years, making it a potential 11 year recuring revenue opportunity, with inflation-based contractual

May 26, 2022 08:30 am ET

Nanalysis Scientific Corp. Announces $160 Million Multi Year Contract Win

CALGARY, AB, May 26, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's wholly-owned subsidiary K'(Prime) Technologies (KPrime) has won a six year $160 million service and maintenance contract with Canadian Air Transportation Security Authority ("CATSA"), which includes a gradual phase in period of approximately one year. Furthermore, it is common for these types of contracts to be renewed for an additional five years, making it a potential 11 year recuring revenue opportunity, with inflation-based cont

May 24, 2022 08:30 am ET

Nanalysis Announces First Quarter 2022 Conference Call and Virtual Annual General Meeting

Hosting Call at 5:00 pm ET on Tuesday, May 31st

May 24, 2022 08:30 am ET

Nanalysis Announces First Quarter 2022 Conference Call and Virtual Annual General Meeting

Hosting Call at 5:00 pm ET on Tuesday, May 31st

Apr 28, 2022 04:05 pm ET

Nanalysis Reports Fourth Quarter and Full Year 2021 Results

Hosting Call Today at 5pm ET

Apr 28, 2022 04:05 pm ET

Nanalysis Reports Fourth Quarter and Full Year 2021 Results

Hosting Call Today at 5pm ET

Apr 20, 2022 08:30 am ET

Nanalysis Announces Fourth Quarter and Full Year 2021 Conference Call

Hosting Call at 5pm ET on Thursday, April 28th

Apr 20, 2022 08:30 am ET

Nanalysis Announces Fourth Quarter and Full Year 2021 Conference Call

Hosting Call at 5pm ET on Thursday, April 28th

Apr 13, 2022 08:30 am ET

/C O R R E C T I O N from Source -- Nanalysis Scientific Corp./

In the news release, Nanalysis Scientific Corp. to Present at NobleCon18, issued 13-Apr-2022 by Nanalysis Scientific Corp. over CNW, we are advised by the company that the date in the first sentence is incorrect. "Wed, April 22nd" should read "Wed, April 20th" as originally issued inadvertently. The complete, corrected release follows:

Apr 13, 2022 08:30 am ET

Nanalysis Scientific Corp. to Present at NobleCon18

CALGARY, AB, April 13, 2022 /CNW/ - Nanalysis Scientific Corp. (TSXV:NSCI) (OTCQX:NSCIF) (FRA:1N1) ("Nanalysis" or the "Company") announces that CEO Sean Krakiwsky will present at NobleCon18, Noble Capital Markets' Eighteenth Annual Investor Conference at the Hard Rock Hotel & Casino, Hollywood, Florida on Wed, April 22nd, 2022 at 12:30 PM ET in Seminole Ballroom B. There is also the opportunity to meet with Mr. Krakiwsky at his breakout sessions scheduled for Wed, April 20, 2022, at 11:30 AM ET at Table 11, Thursday, April 21st at 11:30 AM ET at Table 1, and Thursday, April 21st at 1:4

Apr 13, 2022 08:30 am ET

Nanalysis Scientific Corp. to Present at NobleCon18

CALGARY, AB, April 13, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI) (OTCQX:NSCIF) (FRA:1N1) ("Nanalysis" or the "Company") announces that CEO Sean Krakiwsky will present at NobleCon18, Noble Capital Markets' Eighteenth Annual Investor Conference at the Hard Rock Hotel & Casino, Hollywood, Florida on Wed, April 22nd, 2022 at 12:30 PM ET in Seminole Ballroom B. There is also the opportunity to meet with Mr. Krakiwsky at his breakout sessions scheduled for Wed, April 20, 2022, at 11:30 AM ET at Table 11, Thursday, April 21st at 11:30 AM ET at Table 1, and Thursday, April 21st

Mar 17, 2022 04:05 pm ET

Nanalysis Scientific Corp. Announces $4,985,000 Funding Contribution from the Canadian Government

CALGARY, AB, March 17, 2022 /CNW/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company has received repayable funding of $4,985,000 to expand manufacturing operations and global markets for nuclear magnetic resonance products from the government of Canada.

Mar 17, 2022 04:05 pm ET

Nanalysis Scientific Corp. Announces $4,985,000 Funding Contribution from the Canadian Government

CALGARY, AB, March 17, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company has received repayable funding of $4,985,000 to expand manufacturing operations and global markets for nuclear magnetic resonance products from the government of Canada.

Mar 08, 2022 07:30 am ET

Nanalysis Scientific Corp. Announces Closing of Initial Equity Investment in Quad Systems

CALGARY, AB, March 8, 2022 /CNW/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") in accordance with its press release dated January 18, 2022, the Company announces that it has funded the initial equity investment in Quad Systems AG ("Quad Systems"), acquiring 43% ownership and an option to purchase the remaining shares.

Mar 08, 2022 07:30 am ET

Nanalysis Scientific Corp. Announces Closing of Initial Equity Investment in Quad Systems

CALGARY, AB, March 8, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") in accordance with its press release dated January 18, 2022, the Company announces that it has funded the initial equity investment in Quad Systems AG ("Quad Systems"), acquiring 43% ownership and an option to purchase the remaining shares.

Mar 03, 2022 07:30 am ET

Nanalysis Scientific Corp. Announces Grant of Stock Options

CALGARY, AB, March 3, 2022 /CNW/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted a total of 620,000 stock options to its directors and officers pursuant to the Company's stock option plan. Each option is exercisable to purchase one common share in the capital of the Company at $1.32 per share for a period of five years from the date of issuance. The options vest as to one-third on each of the 12 month, 24 month and 36 month anniversary date of grant.

Mar 03, 2022 07:30 am ET

Nanalysis Scientific Corp. Announces Grant of Stock Options

CALGARY, AB, March 3, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted a total of 620,000 stock options to its directors and officers pursuant to the Company's stock option plan. Each option is exercisable to purchase one common share in the capital of the Company at $1.32 per share for a period of five years from the date of issuance. The options vest as to one-third on each of the 12 month, 24 month and 36 month anniversary date of grant.

Feb 24, 2022 07:30 am ET

Nanalysis Recognized as a Top 5 Ranked Company by the TSX Venture 50 for 2021

CALGARY, AB, Feb. 24, 2022 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable MRI and NMR machines for healthcare and industrial applications, is pleased to announce that it has ranked in the top 5 performing Clean Tech and Life Sciences stocks in the 2021 TSX Venture 50™, which is comprised of the top 50 from over 1,600 companies on the TSX Venture Exchange. The selected Venture 50™ companies have seen tremendous growth over 2021, offered excellent returns to their shareholders, and are actively traded in the market.

Feb 24, 2022 07:30 am ET

Nanalysis Recognized as a Top 5 Ranked Company by the TSX Venture 50 for 2021

CALGARY, AB, Feb. 24, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable MRI and NMR machines for healthcare and industrial applications, is pleased to announce that it has ranked in the top 5 performing Clean Tech and Life Sciences stocks in the 2021 TSX Venture 50™, which is comprised of the top 50 from over 1,600 companies on the TSX Venture Exchange. The selected Venture 50™ companies have seen tremendous growth over 2021, offered excellent returns to their shareholders, and are actively traded in the market.

Feb 17, 2022 03:05 pm ET

Nanalysis Provides Corporate Update

Holding Call at 5pm ET Today

Feb 17, 2022 03:05 pm ET

Nanalysis Provides Corporate Update

Holding Call at 5pm ET Today

Feb 11, 2022 07:30 am ET

Nanalysis Scientific Corp. Closes Upsized Public Offering and Non-Brokered Private Placement For Gross Proceeds of $15,224,700

CALGARY, AB, Feb. 11, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that it has closed the previously announced best efforts marketed public offering (the "Public Offering") of common shares (the "Common Shares") of the Company, including the full exercise of the over-allotment option and the non-brokered private placement of Common Shares (the "Private Placement") for combined gross proceeds of $15,224,700.70.

Feb 10, 2022 07:30 am ET

Nanalysis Announces Corporate Update Conference Call

Hosting Call at 5pm ET on Thursday, February 17th

Jan 28, 2022 10:07 am ET

36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.

Jan 27, 2022 08:28 am ET

NANALYSIS SCIENTIFIC CORP. ANNOUNCES UPSIZE TO MARKETED PUBLIC OFFERING

/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES./

Jan 24, 2022 09:14 am ET

Nanalysis Named to 2022 OTCQX Best 50

CALGARY, AB, Jan. 24, 2022 /CNW/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") is pleased to announce it has been named to the 2022 OTCQX® Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year.

Jan 20, 2022 03:13 pm ET

NANALYSIS SCIENTIFIC CORP. ANNOUNCES MARKETED PUBLIC OFFERING OF UP TO C$8 MILLION

/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES/

Jan 18, 2022 07:30 am ET

Nanalysis Enters into a Letter of Intent to Acquire Quad Systems AG

CALGARY, Alberta, Jan. 18, 2022 /CNW/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") is pleased to announce that it has entered into a letter of intent to acquire QUAD Systems AG (Quad Systems), a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

Jan 18, 2022 07:30 am ET

Nanalysis Enters into a Letter of Intent to Acquire Quad Systems AG

CALGARY, Alberta, Jan. 18, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") is pleased to announce that it has entered into a letter of intent to acquire QUAD Systems AG (Quad Systems), a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

Jan 12, 2022 07:30 am ET

Nanalysis Announces the Closing of Acquisition of K'(Prime) Technologies Inc.

CALGARY, AB, Jan. 12, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") is pleased to announce that it has successfully closed the previously announced acquisition of K'(Prime) Technologies Inc. (KPrime), a North American sales and service company, with a particular focus on scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications.

Jan 12, 2022 07:30 am ET

Nanalysis Announces the Closing of Acquisition of K'(Prime) Technologies Inc.

CALGARY, AB, Jan. 12, 2022 /CNW/ - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") is pleased to announce that it has successfully closed the previously announced acquisition of K'(Prime) Technologies Inc. (KPrime), a North American sales and service company, with a particular focus on scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications.

Dec 22, 2021 07:30 am ET

Nanalysis Establishes Scientific Advisory Board with Four World Renowned Scientists

CALGARY, AB, Dec. 22, 2021 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") is pleased to announce that, effective December 21, 2021, it has established a Scientific Advisory Board, with four world renowned scientists as founding members, including Dr. Matt Rosen of Harvard Medical School and co-founder of Hyperfine.

Dec 22, 2021 07:30 am ET

Nanalysis Establishes Scientific Advisory Board with Four World Renowned Scientists

CALGARY, AB, Dec. 22, 2021 /CNW/ - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") is pleased to announce that, effective December 21, 2021, it has established a Scientific Advisory Board, with four world renowned scientists as founding members, including Dr. Matt Rosen of Harvard Medical School and co-founder of Hyperfine.

Dec 15, 2021 07:30 am ET

Nanalysis Appoints Dr. René Lenggenhager to Board of Directors

CALGARY, AB, Dec. 15, 2021 /PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company"), TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) is pleased to announce that, effective January 1, 2022, Dr. René Lenggenhager, is joining its Board of Directors. Dr. Lenggenhager is an experienced public company executive and board member with a successful career in leading global technology companies. In addition, the Company is pleased to announce that Dr. Lenggenhager is investing in Nanalysis via non-brokered private placement of 150,000 common shares of the Company ("Common Shares") at a price of $1.35

Dec 15, 2021 07:30 am ET

Nanalysis Appoints Dr. René Lenggenhager to Board of Directors

CALGARY, AB, Dec. 15, 2021 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company"), TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) is pleased to announce that, effective January 1, 2022, Dr. René Lenggenhager, is joining its Board of Directors. Dr. Lenggenhager is an experienced public company executive and board member with a successful career in leading global technology companies. In addition, the Company is pleased to announce that Dr. Lenggenhager is investing in Nanalysis via non-brokered private placement of 150,000 common shares of the Company ("Common Shares") at a price of $1.35 per sh

Dec 01, 2021 07:30 am ET

Nanalysis to Present at December Investor Conferences

CALGARY, AB, Dec. 1, 2021 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) will be presenting at three upcoming investor conferences in December. We encourage shareholders to listen in and book meetings in order to stay up to date with our developments.

Nov 18, 2021 03:05 pm ET

Nanalysis Announces Third Quarter 2021 Results

Year to date revenue growth of 110%

Nov 10, 2021 08:02 am ET

Nanalysis Merges with K'(Prime) Technologies Inc.

Nov 05, 2021 12:00 pm ET

Sidoti Microcap Virtual Conference

A Conference Open to All Classes of Investors70+ Companies Presenting and Meeting Interested Investors 1x1Wednesday and Thursday, December 8-9, 2021

Nov 04, 2021 08:30 am ET

Nanalysis Announces Third Quarter 2021 Conference Call

Hosting Call at 5pm ET on Thursday, November 18th

Oct 21, 2021 08:30 am ET

Nanalysis Scientific Corp. Announces Normal Course Issuer Bid

CALGARY, AB, Oct. 21, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that it has received conditional acceptance from the TSX Venture Exchange to make a Normal Course Issuer Bid ("NCIB") to purchase for cancellation, during the 12-month period starting October 25, 2021, up to 3,844,081 of the Common Shares, representing 5% of the Common Shares outstanding as of October 25, 2021. The program will end on October 24, 2022, the maximum amount of Common Shares is purchased before then or Nanalysis provides earlier notice of ter

Oct 19, 2021 08:30 am ET

Nanalysis Hires Firm IR Group for Investor Relations

CALGARY, AB, Oct. 19, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable MRI and NMR machines for healthcare and industrial applications, announces that it has retained Firm IR Group as an investor relations advisor. Firm IR Group will assist the Company with its investor relations program consisting of corporate communications, investor and shareholder outreach.

Oct 05, 2021 12:20 am ET

Update: Fall Harvest Best Ideas Presentation Time Change

CALGARY, AB / ACCESSWIRE / October 5, 2021 / Nanalysis Scientific Corp. ("Nanalysis") (TSXV:NSCI)(OTCQX:NSCIF)(FRA:1N1) would like to announce a time change for our upcoming presentation at the Fall Harvest Best Ideas conference. Nanalysis is scheduled to present at 11:30 - 12:00 ET. One-on-one meetings with management will still be held throughout the conference from Oct 6-8. The presentation will be webc

Oct 04, 2021 04:30 pm ET

36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021

RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th - 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.

Sep 30, 2021 07:11 pm ET

Nanalysis Fall Investor Presentation Schedule

CALGARY, AB / ACCESSWIRE / September 30, 2021 / Nanalysis Scientific Corp. ("Nanalysis") (TSXV:NSCI)(OTCQX:NSCIF)(FRA:1N1), is pleased to share its fall investor conference schedule.

Sep 07, 2021 03:55 pm ET

Nanalysis Scientific Corp. to Present at the 10th Annual Gateway Conference on September 9, 2021

CALGARY, AB / ACCESSWIRE / September 7, 2021 / Nanalysis Scientific Corp. (TSXV:NSCI)(OTCQX:NSCIF) has been invited to present at the 10th Annual Gateway Conference, which is being held virtually on September 8-9, 2021.

Aug 26, 2021 06:54 pm ET

Nanalysis Scientific Corp. Reports Second Quarter 2021 Financial Results

CALGARY, AB, Aug. 26, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), released today its second quarter 2021 results.

Aug 25, 2021 10:27 am ET

Nanalysis Scientific Corp. Closes Bought Deal Public Offering and Concurrent Non-Brokered Private Placement for Gross Proceeds of C$10,997,686

CALGARY, AB, Aug. 25, 2021 /CNW/ - Nanalysis Scientific Corp. Nanalysis Scientific Corp. ("the Company"), (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), announces it has closed the previously-announced underwritten public offering (the "Public Offering") of units (the "Units") of the Company and the concurrent non-brokered private placement of Units (the "Private Placement") for combined gross proceeds of C$10,997,686.40.

Jul 29, 2021 08:04 am ET

Nanalysis Scientific Corp. Announces $8 Million "Bought Deal" Public Offering

/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES/

Jul 28, 2021 08:40 pm ET

Nanalysis announces closing of acquisition of One Moon Scientific

CALGARY, AB, July 28, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that it has successfully closed the previously announced acquisition of One Moon Scientific ("OMS"), a New York based magnetic resonance software company that specializes in a suite of software tools to streamline and automate Magnetic Resonance ("MR") data analysis and management.

Jul 21, 2021 08:45 pm ET

Nanalysis Acquires New York Based Software Company

CALGARY, AB, July 21, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that it has acquired 100 percent of One Moon Scientific ("OMS"), a New York based magnetic resonance software company. This acquisition opens up new industry verticals for hardware sales and allows for software licensing and SAAS revenue.

Jul 13, 2021 04:30 pm ET

Nanalysis Announces Q2 2021 Revenue up 120% over Q2 2020

CALGARY, AB, July 13, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable MRI and NMR machines for healthcare and industrial applications, announced quarterly preliminary revenue of $4.4 million in Q2 of 2021, a 120% increase over Q2 2020.

Jul 06, 2021 09:19 pm ET

Investor Relations Initiative

CALGARY, AB, July 6, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), would like to announce that it has engaged North Equities, Stonegate Capital Partners, and Peterson Capital in order to increase company visibility and share our story with a broad range of new investors. The Company's CEO, Sean Krakiwsky, has noted a number of times that he views the company as being discounted in the market and this initiative is intended to raise awareness of our exciting story with a broader audience across North America.

May 20, 2021 04:36 am ET

Nanalysis Scientific Corp. Reports First Quarter 2021 Financial Results

CALGARY, AB, May 20, 2021 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), released today its first quarter 2021 results.

Apr 22, 2021 08:53 pm ET

Nanalysis Scientific Corp. Reports Fourth Quarter and Annual 2020 Results

CALGARY, AB, April 22, 2021 /CNW/ - Nanalysis Scientific Corp. (Nanalysis, TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), released today its fourth quarter and annual 2020 results.

Mar 26, 2021 09:23 pm ET

Nanalysis Scientific Corp. Announces Grant of Options and Restricted Share Units

CALGARY, AB, March 26, 2021 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that the Board of Directors has granted 100,000 stock options to a director of the Company in accordance with the Company's stock option plan. Each option is exercisable to purchase one common share of the Company (a "Common Share") at $0.60 per share, the expiry period is five years from the date of issuance and the options vest over three years.

Feb 26, 2021 09:49 pm ET

Nanalysis Scientific Corp. Announces Grant of Options and Restricted Share Units

CALGARY, AB, Feb. 26, 2021 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that the Board of Directors has granted 1,048,000 stock options to certain directors, officers, employees and consultants in accordance with the Company's stock option plan. Each option is exercisable to purchase one common share of the Company (a "Common Shares") at $0.60 per share for a period of five years from the date of issuance. Of the total 1,048,000 stock options, 5% or 50,000 were granted to an officer and director of the Company, a

Jan 12, 2021 11:14 pm ET

Nanalysis Scientific Corp. Signs Strategic OEM Partnership for Magnetic Resonance Electronics Sales

CALGARY, AB, Jan. 12, 2021 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis"),(TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), through its subsidiary RS2D S.A.S. ("RS2D"), is pleased to announce that it has signed multi-million dollar OEM and licensing deal with a European corporation.

Jan 05, 2021 09:00 pm ET

Nanalysis Begins Customer Shipments for New 100 MHz NMR Product

CALGARY, AB, Jan. 5, 2021 /CNW/ - Nanalysis Scientific Corp. (Nanalysis, TSXV: NSCI OTCQX: NSCIF FRA: 1N1), is pleased to announce that it has shipped the first four units of its new 100 MHz product to customers. Current sales backlog of this product is over $4.5 million and growing.

Dec 10, 2020 09:13 pm ET

Nanalysis Wins European Competitive Bid with NextGen MRI System for Personalized Medicine Research

STRASBOURG, France, Dec. 10, 2020 /CNW/ - Nanalysis Scientific Corp. (Nanalysis), (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), through its subsidiary RS2D S.A.S. (RS2D), is pleased to announce that it has won a C$1.2M non-repayable grant to further leverage its proprietary Nuclear Magnetic Resonance Imaging (MRI) technology for smart NextGen clinical MRI systems. This product, based on the Cameleon4TM Original Equipment Manufacturer (OEM) product, will advance these devices an additional step towards the personalized medicine of the future.

Nov 27, 2020 06:45 am ET

Nanalysis Scientific Inc. Reports Third Quarter 2020 Results and Provides Business Update

CALGARY, AB, Nov. 27, 2020 /CNW/ - Nanalysis Scientific Corp. ("the Company"), (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) released today its third quarter 2020 results and provided an update on business operations.

Aug 31, 2020 05:00 pm ET

(LD Micro) 360 Companies Set to Present this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

Aug 24, 2020 09:09 am ET

Nanalysis Scientific Inc. Reports Second Quarter 2020 Results

CALGARY, AB, Aug. 24, 2020 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) released today its second quarter 2020 results.

Aug 05, 2020 09:00 am ET

LD Micro - Announces Preliminary List of Presenters for the LD 500

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

Jul 02, 2020 08:28 pm ET

Nanalysis Scientific Corp. Announces Grant of Restricted Share Units

CALGARY, AB, July 2, 2020 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) is pleased to announce that the Board of Directors approved on July 1, 2020 the granting of 40,000 restricted share units ("RSUs" ) to each director of the Company pursuant to the Company's Restricted Share Unit Plan (the "RSU Plan") for a total of 160,000 RSUs. These RSUs vest in two stages, one-half 18 months from the date of grant and one-half 36 months from the date of grant. Each vested RSU entitles the holder to receive one common share of the Company (a "

May 28, 2020 02:58 am ET

Nanalysis Scientific Corp. Reports First Quarter 2020 Results

CALGARY, May 28, 2020 /CNW/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) released today its first quarter 2020 results.

May 14, 2020 09:41 pm ET

Nanalysis Announces New Board Member

CALGARY, May 14, 2020 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or "the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) announces today that Mr. Steve Meszaros has resigned from the company's board of directors for personal reasons, effective May 13, 2020.

Apr 23, 2020 06:18 am ET

Nanalysis Scientific Corp. Reports Fourth Quarter and Annual 2019 Results

CALGARY, April 23, 2020 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) released its fourth quarter and annual 2019 results today.

Apr 16, 2020 07:05 pm ET

Nanalysis to Present at the Planet MicroCap Virtual Showcase Investor Conference 2020

CALGARY, ALBERTA, CANADA / ACCESSWIRE / April 16, 2020 / Nanalysis Scientific Corp. ("Nanalysis") (TSXV: NSCI)(OTCQX:NSCIF)(FRA: 1N1) is excited to announce that it will be participating in the Planet MicroCap Virtual Showcase 2020 on Wednesday, April 22.

Apr 06, 2020 09:14 pm ET

Nanalysis Business Update and COVID-19 Impact

CALGARY, April 6, 2020 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) would like to provide an update on our business to our investors, given the global coronavirus pandemic.

Apr 06, 2020 07:00 am ET

OTC Markets Group Welcomes Nanalysis Scientific Corp. to OTCQX

NEW YORK, April 6, 2020 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Nanalysis Scientific Corp. (TSX-V: NSCI; OTCQX: NSCIF), a scientific instrument manufacturer based in Calgary, has qualified to trade on the OTCQX® Best Market. Nanalysis Scientific Corp. upgraded to OTCQX from the Pink® market.

Mar 06, 2020 01:07 pm ET

Nanalysis Celebrates Closing of RS2D Acquisition with French Ambassador

PARIS, March 6, 2020 /CNW/ - Nanalysis Scientific Corp. (Nanalysis, TSXV:NSCI, FRA:1N1) is joined by the Canadian ambassador to France, Ms. Isabelle Hudon at the Canadian Embassy in Paris to commemorate the formal closing of the Nanalysis-RS2D S.A.S. (RS2D) acquisition. The agreement was finalized March 3, 2020 in Strasbourg, France. Nanalysis met with the Canadian ambassador to France, Ms. Isabelle Hudon at the Canadian Embassy in Paris to commemorate the formal closing.

Feb 23, 2020 11:14 pm ET

Nanalysis Acquires European NMR/MRI Company

CALGARY, Feb. 23, 2020 /CNW/ - Nanalysis Scientific Corp. (Nanalysis, TSXV:NSCI, FRA:1N1) is pleased to announce that it has entered into a contract to acquire 100 percent of RS2D S.A.S. (RS2D), a global leader in next-gen electronics for MRI and NMR systems. Closing of the acquisition is scheduled for Thursday, February 27, 2020.

Feb 18, 2020 07:42 pm ET

Nanalysis Wins 'Best New Analytical Product' at Top Nanotechnology Exhibition in Japan

CALGARY, Feb. 18, 2020 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis", TSXV:NSCI) is pleased to announce that it won the award for 'Best New Analytical Product' at the recent Nanotech Exhibition and Conference in Tokyo, Japan. Nanalysis was the only small-cap, non-Japanese company to win an award. The award, coupled with strong positive feedback from conference attendees, provided further validation for the market opportunity Nanalysis seeks to capitalize on with its 60 and 100 MHz NMR spectrometers.

Jan 29, 2020 08:00 am ET

SARTEC and Nanalysis Combine AI and NMR for Oil Refinery Solutions

CALGARY and ASSEMINI (CAGLIARI), Italy, Jan. 29, 2020 /CNW/ - Nanalysis Scientific Corp. ("Nanalysis", TSXV: NSCI) and SARAS Ricerche e Tecnologie S.r.l. ("SARTEC") are pleased to announce that as of January 27, they have entered into a collaboration agreement to jointly develop process analytical solutions for the oil & gas industry, including the analysis of crude oil for the oil refineries.

Dec 10, 2019 03:01 pm ET

The German LKA and Nanalysis Announce Joint Product Development Collaboration

CALGARY, Dec. 10, 2019 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis", TSXV:NSCI), is pleased to announce it has entered into a collaboration agreement with the "Krimaltechnisches Institut" of the Landeskriminalamt of Lower Saxony (LKA NI) to develop a mobile detector for the identification and quantification of illegal street drugs. The benchtop NMR based testing method will be automated such that it does not require a specially trained operator. Additionally, as the test is non-destructive, the sample is not destroyed and can be used for repetitive testing; facilitating s

Nov 26, 2019 07:01 pm ET

Nanalysis Announces Third Quarter (Q3) 2019 Financials

CALGARY, Nov. 26, 2019 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis", TSXV:NSCI), a global leader in magnetic resonance for industrial applications, announces today the filing on Sedar.com of its third quarter (Q3) financial statements for the period ended September 30, 2019 and related MD&A.

Oct 28, 2019 04:23 pm ET

Bosch and Nanalysis Announce Joint Product Development Collaboration

CALGARY, Oct. 28, 2019 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis", TSXV:NSCI), is pleased to announce that as of October 23rd, it has entered into a collaboration agreement with Robert Bosch GmbH (Bosch) to jointly develop products for the growing market industrial Nuclear Magnetic Resonance (NMR) products for applications such as on-board fuel analyzers for cargo ships, driven by new international environmental standards against dirty fuels, which would be distributed by Bosch. The collaborative work will begin in November 2019 and joint development effort is expected

Oct 24, 2019 07:36 pm ET

Nanalysis Appoints New Chief Financial Officer

CALGARY, Oct. 24, 2019 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis", TSX-V: NSCI), is pleased to announce that Luke Caplette is joining the company as its Chief Financial Officer (CFO). Mr. Caplette, CPA/CA, spent the early part of his career at Ernst & Young as Senior Accountant and was most recently CFO at Cordy Oilfield Services Inc.

Aug 28, 2019 09:00 am ET

Nanalysis Announces Second Quarter (Q2) 2019 Financials

CALGARY, Aug. 28, 2019 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis", TSX-V:NSCI), a global leader in magnetic resonance for industrial applications, announced today its second quarter (Q2) financial results for the period ended June 30, 2019.

Aug 26, 2019 09:00 am ET

Nanalysis Announces the Launch of its New 100MHz Compact NMR Device

CALGARY, Aug. 26, 2019 /CNW/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis", TSX-V:NSCI), is pleased to announce the world's first ever 100 MHz compact NMR device with unprecedented performance metrics including superior resolution and sensitivity, plus over 25% better signal dispersion than any competing compact NMR device on the market.

Jul 17, 2019 09:00 am ET

Ad blocking detected

Nanalysis Scientific Corp. (V:NSCI)

Business Focus: Advanced Medical Equipment & Technology (NEC)